Azimutus is a leading independent advisory firm specializing in M&A transaction advisory and growth capital. Established in 2004, it has completed over 150 projects. The firm supports clients in buy-side and sell-side processes and related strategic advisory. Azimutus has a strong focus on biotech and healthcare with a specialist team based in Oxford. The firm operates in Europe with offices in Poland, Switzerland, the United Kingdom, and Belgium.